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This Article contains errors in Figures 6b and 6c where the 'shRNA' axes labels are missing. Additionally, in Figure 6D, 'shRNA' is erroneously included as part of the 'ZEB1/GAPDH' label. The correct Figure 6 appears below as Figure [1](#Fig1){ref-type="fig"}.Figure 1Snail is essential for expression and promoter activation of MMP9 and ZEB1. HepG2 cells were transfected with none (MOCK) or plasmids encoding indicated Snail shRNAs (**A**,**B**,**C**) and control shRNA of Lamin (**A**), (**B**) or GFP (**C**) for 24 h followed by untreated (MOCK) or treated with 50 nM TPA for 4 h (**A**); 4 and 6 h for ZEB1 and MMP9, respectively (**B**); or 12 h (**C**). HCC340 were transfected with pcDNA3 vector or Snail expressing plasmid (p-Snail) for 36 h (**D**) and (**E**). RT-PCR (**A**), (**D**) and quantitative RT-PCR (**B**), (**E**) of Snail, MMP9 and ZEB1 and promoter assay of MMP9-950 (C, upper panel) and ZEB1-1079 (C, lower panel) were performed. In (**A**,**D**), the numbers below each figure are the ratios of relative mRNA based on RT-PCR of indicated transcriptional factor *vs* GAPDH, taking the data of MOCK (**A**) and pcDNA3 (**D**) as 1.0. The results are average of 3 reproducible experiments with C.V. of 7.5%. In (**B**) and (**E**), the relative mRNA was calculated based on real time RT-PCR, taking the data of MOCK (**B**) and pcDNA3 (**E**) as 1.0. In (**C)**, the relative dual luciferase activity of MMP9-950 or ZEB1-1079 was calculated, taking MOCK as 1.0. The data in (**B**), is average of two representative experiment with C.V. of 12%. In (**C**) and (**E**), (\*\*^,^\*) represent the statistically significant difference (p \< 0.005, N = 3), (p \< 0.05, N = 3) between the indicated samples and the control GFP shRNA (**C**) and pcDNA3 (**E**) group.
